Form 4 for RLYB Rallybio Corp
Accepted 2022-03-23 00:00:00 ET · period of report 2022-03-21 · accession 0000899243-22-011950 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-03-23 | 2022-03-21 | RLYB | Fryer Jeffrey M | See Remarks | P - Purchase | $8.04 | +3,000 | 47.0K | +7% | +$24.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-21 | P | A | 3,000 | $8.04 | 47,048 | I See Footnote | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.00 to $8.99, inclusive. The reporting person undertakes to provide to Rallybio Corporation, any security holder of Rallybio Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. (F2) Shares of common stock are held in a Roth IRA. |